Araceli Biosciences

Tigard, Oregon, United States

Drug Discovery Biomarker Monitoring Drug Development Life Sciences

Araceli Bioscience is a healthcare startup focused on creating cutting-edge technology to empower researchers and accelerate therapeutic discovery. The company offers innovative solutions such as the Endeavor® Clairvoyance™ software, which is an automation-compatible platform designed to enhance predictive AI-based image acquisition and analysis. Their goal is to enable informed decision-making and increase the success rates of therapeutic developments, striving to make the drug discovery process more efficient. By pairing fast and easy-to-use hardware with advanced artificial intelligence analysis algorithms, Araceli aims to transform the drug discovery pipeline, allowing customers to fail faster and reduce the time and bandwidth required to screen compounds. They provide high-performance scientific tools for tissue and cell-based biomarker discovery, contributing significantly to drug development efforts.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Araceli Biosciences on @MedStartr Today #DrugDiscovery #DrugDevelopment #AllTherapeuticAreas #BiomarkerMonitoring #LifeSciencesBiopharma #MedMo #MedStartrVentures

https://www.medstartr.ai/s/GOAU23KTJ5E

Get Involved in Araceli Biosciences

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2022
Website: www.aracelibio.com/

Disease Areas

Drug Discovery Drug Development All Therapeutic Areas

Technologies

Biomarker DiscoveryDrug DiscoveryHigh-Throughput AutomationLife Sciences R&D

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Araceli Biosciences?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.